Recommendations for Neuromodulation in Diabetic Neuropathic Pain

Recommendations for Neuromodulation in Diabetic Neuropathic Pain

Over 50% of the 34 million people who suffer from diabetes mellitus (DM) are affected by diabetic neuropathy. Painful diabetic neuropathy (PDN) impacts 40–50% of that group (8.5 million patients) and is associated with a significant source of disability and economic burden. Though new neuromodulatio...

Full description

Bibliographic Details
Main Authors: Zachary T. Olmsted, Amir Hadanny, Anthony M. Marchese, Marisa DiMarzio, Olga Khazen, Charles Argoff, Vishad Sukul, Julie G. Pilitsis
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Pain Research
Subjects:
neuropathic pain
painful diabetic neuropathy
diabetes mellitus
neuromodulation
pharmacotherapy
pain management
Online Access:https://www.frontiersin.org/articles/10.3389/fpain.2021.726308/full

Internet

https://www.frontiersin.org/articles/10.3389/fpain.2021.726308/full

Similar Items